Related Experiment Video
Updated: Oct 2, 2025
06:14
The Isolation of Flowing Mesenteric Lymph in Mice to Quantify In Vivo Kinetics of Dietary Lipid Absorption and Chylomicron Secretion
Published on: November 30, 2022
2.8K
Measurement of In Vivo VLDL and Chylomicron Secretion
Siddhartha S Ghosh1, Jing Wang1, Shobha Ghosh2,3
1Department of Internal Medicine, Virginia Commonwealth University Medical Center, Richmond, VA, USA.
Methods in Molecular Biology (Clifton, N.J.)
|February 25, 2022
Summary
This study details methods to measure chylomicron and very low-density lipoprotein (VLDL) secretion in vivo. Understanding lipoprotein secretion is crucial for studying diet
Area of Science:
- Metabolic research
- Lipid metabolism
- Gastroenterology
Background:
- Dietary lipid absorption and chylomicron secretion by enterocytes reflect dietary lipid availability.
- Very low-density lipoprotein (VLDL) secretion from the liver is a key indicator of hepatic lipid homeostasis.
- Dysregulation of these processes contributes to dyslipidemia and non-alcoholic fatty liver disease (NAFLD).
Purpose of the Study:
- To describe methodologies for specifically measuring in vivo chylomicron and VLDL secretion.
- To highlight the importance of quantifying lipoprotein secretion in understanding metabolic diseases.
Main Methods:
- In vivo measurement of chylomicron secretion.
- In vivo measurement of very low-density lipoprotein (VLDL) secretion.
Main Results:
- Established methods for specific in vivo measurement of chylomicron and VLDL secretion.
- Demonstrated the link between lipoprotein secretion and metabolic health.
Conclusions:
- Accurate measurement of lipoprotein secretion is vital for investigating dietary lipid effects and metabolic disorders.
- This research provides tools to study dyslipidemia, NAFLD, and non-alcoholic steatohepatitis (NASH).
